Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP705038.RAlggPNOdV2S6URV1rANRbscrNBsrXPZPUZFvn0yd8Swo130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705038.RAlggPNOdV2S6URV1rANRbscrNBsrXPZPUZFvn0yd8Swo130_provenance.
• NP902589.RASEeHyzBdFLZu51XRSog8N1ScCV8ICHbrxazkJDOYT6Q130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902589.RASEeHyzBdFLZu51XRSog8N1ScCV8ICHbrxazkJDOYT6Q130_provenance.
• NP795294.RAR_q7e5hAiKK--WrKzKHyJJTIm_9IIUg3s9JmAu3X-aQ130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795294.RAR_q7e5hAiKK--WrKzKHyJJTIm_9IIUg3s9JmAu3X-aQ130_provenance.
• NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_provenance.
• NP799943.RAw9fhKv5dgdo5Ne_XdZNzarvujUSaCM_7NAs0LWANxP8130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799943.RAw9fhKv5dgdo5Ne_XdZNzarvujUSaCM_7NAs0LWANxP8130_provenance.
• assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232519.RApaX6Ze-J_WL1N2IL5YDuDjb1WX6x94UbX20xvNdrU2A130_provenance.
• NP547303.RAo74Wxx0tOaZiEtLrWPd_F1Vo7Rnnd5vlfFY4KX3QIHE130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547303.RAo74Wxx0tOaZiEtLrWPd_F1Vo7Rnnd5vlfFY4KX3QIHE130_provenance.
• NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_provenance.
• NP621651.RAy_fthH1i3Btelz5-nHZYheo5Ju2rDrA9OsAEeQg3MXs130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621651.RAy_fthH1i3Btelz5-nHZYheo5Ju2rDrA9OsAEeQg3MXs130_provenance.
• NP624217.RA97o-H3jsIJFM3Ih91Q3SUaaN8EYnFNOtDd3cnIOqw0Q130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624217.RA97o-H3jsIJFM3Ih91Q3SUaaN8EYnFNOtDd3cnIOqw0Q130_provenance.
• NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625357.RA5ogqmqVRbwnEtwB0lsXt5vsLxt0NMMj2P-AS65Drq78130_provenance.
• NP547299.RAxoMH0MJBDLllOueQ9CRMOCmKVSrrg7TL8ZBxGoYg47g130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547299.RAxoMH0MJBDLllOueQ9CRMOCmKVSrrg7TL8ZBxGoYg47g130_provenance.
• NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547302.RA7EQyMn31eplls9Qf1T-hwnyNJfdc72EVTOzAHkDU_V4130_provenance.
• NP547304.RA8b_FpE6-QwYSjkEzb4B2NYumQgeJTpcOfC_S4Fkae-o130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547304.RA8b_FpE6-QwYSjkEzb4B2NYumQgeJTpcOfC_S4Fkae-o130_provenance.
• NP547305.RA5PhXa7Bfb8HZff7aOIdfywBmEyR0V84R61tJAC993Hw130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547305.RA5PhXa7Bfb8HZff7aOIdfywBmEyR0V84R61tJAC993Hw130_provenance.